Today was an exciting day for Nutra Pharma at the World MoneyShow in Orlando, Florida. Our booth (#817) was busy the entire day with conference attendees stopping by to learn more about our company, our recently launched pain relievers, Cobroxin and Nyloxin, and our drug pipeline.
Throughout the day, we continued to offer free samples of Cobroxin Topical Gel. This turned out to be a great opportunity to build our Cobroxin brand awareness, especially when several attendees made it a point to come back to the booth to share with us, first hand, how well Cobroxin worked to relieve their pain.
On the Nutra Pharma Blog are several images from the conference, including photos taken at the Nutra Pharma presentation, a standing-room only event given by the Company’s Chairman and CEO, Rik J. Deitsch.
About Nutra Pharma Corp.
Nutra Pharma Corporation (the "Company") operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. The Company, through its subsidiaries, carries out basic drug discovery research and clinical development, and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. Nutra Pharma's wholly-owned drug discovery subsidiary, ReceptoPharm, is developing proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Additionally, ReceptoPharm provides contract research services through its ISO class 5 and GMP certified facilities. The Company's wholly-owned medical devices subsidiary, Designer Diagnostics, engages in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases, such as Nontuberculous Mycobacteria (NTM). Nutra Pharma continues to identify intellectual property and companies in the biotechnology arena that it investigates about possibly acquiring or establish strategic partnerships with.
http://www.NutraPharma.com
http://www.Cobroxin.com
Undiscovered Equities is currently offering a complimentary trial subscription.
To view our newsletter on a complimentary trial basis and take advantage of our other services go to www.undiscoveredequities.com and join our email list on our home page.
Kevin McKnight
1-800-404-8982
Undiscovered Equities, Inc.
101 Plaza Real, Suite 212
Boca Raton, FL 33432
www.undiscoveredequities.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment